BackgroundCheck.run
Search For

Qian Zhao, 44Raleigh, NC

Known as:
Quian Zhao None Zhao Qian
Related to:
Huizhen Hu Heather Hu 67 Danya Hu 27 Shang H Hong 67 Xiao Y Wang 62

Qian Zhao Phones & Addresses

Raleigh, NC   

Lexington, MA   

Ridgeland, MS   

Durham, NC   

Logan, UT   

Wade, NC   

Work

Company: Unc information technology services Aug 2012 Position: Control center administrator

Education

School / High School: University of North Carolina at Chapel Hill- Chapel Hill, NC 2012 Specialities: Bachelor of Science in Chemistry with a focus in Biochemistry

Skills

Graphic Design • Illustration • Troubleshooting • Research • Microsoft Office Suite • Adobe Photoshop and Illustrator • Windows and Mac OS • good spacial awareness.

Ranks

Licence: New York - Due to reregister within 30 days of birthday Date: 1999
Get Report
Control this profile

Mentions for Qian Zhao

Career records & work history

Lawyers & Attorneys

Qian Zhao Photo 1

Qian Zhao - Lawyer

Address:
Skadden Arps Slate Meagher & Flom LLP
106-5055511 (Office)
Licenses:
New York - Due to reregister within 30 days of birthday 1999
Education:
New York University School of Law

Medicine Doctors

Qian Zhao

Specialties:
Cardiovascular Disease
Work:
Interventional Heart GroupCardiac Interventional Group
100 Prt Washington Blvd STE 105, Roslyn, NY 11576
516-3909640 (phone) 516-3909650 (fax)
Site
Education:
Medical School
The Fourth Military Med Univ, Xian City, Shaanxi, China
Graduated: 1995
Procedures:
Cardiac Stress Test, Continuous EKG, Echocardiogram, Electrocardiogram (EKG or ECG)
Conditions:
Acute Myocardial Infarction (AMI), Atrial Fibrillation and Atrial Flutter, Cardiac Arrhythmia, Conduction Disorders, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Gastrointestinal Hemorrhage, Heart Failure, Hypertension (HTN), Ischemic Heart Disease, Overweight and Obesity, Pulmonary Embolism, Substance Abuse and/or Dependency, Acute Bronchitis, Acute Pancreatitis, Anemia, Angina Pectoris, Aortic Valvular Disease, Attention Deficit Disorder (ADD), Bipolar Disorder, Bronchial Asthma, Cardiomyopathy, Cholelethiasis or Cholecystitis, Chronic Renal Disease, Congenital Anomalies of the Heart, Diverticulitis, Epilepsy, Gastroesophageal Reflux Disease (GERD), Hypothyroidism, Infectious Liver Disease, Inguinal Hernia, Ischemic Stroke, Mitral Valvular Disease, Obstructive Sleep Apnea, Paroxysmal Supreventricular Tachycardia (PSVT), Peptic Ulcer Disease, Pneumonia, Poisoning by Drugs, Meds, or Biological Substances, Rheumatoid Arthritis, Septicemia, Sickle-Cell Disease, Skin and Subcutaneous Infections, Thoracid Aortic Aneurysm, Transient Cerebral Ischemia, Urinary Tract Infection (UT), Ventral Hernia
Languages:
English, Spanish
Description:
Dr. Zhao graduated from the The Fourth Military Med Univ, Xian City, Shaanxi, China in 1995. She works in Roslyn, NY and specializes in Cardiovascular Disease. Dr. Zhao is affiliated with Mid Hudson Regional Hospital Of Westchester Medical Center.
Qian Zhao Photo 2

Qian DR Zhao

Specialties:
Internal Medicine
Cardiovascular Disease
Cardiology
Education:
The Fourth Military Med Univ (1995)

License Records

Qian Zhao

Licenses:
License #: 40249 - Active
Category: Professional
Issued Date: Dec 11, 2003
Expiration Date: Dec 31, 2018

Qian Zhao resumes & CV records

Resumes

Qian Zhao Photo 39

Postdoctoral Associate At Duke University

Location:
Raleigh-Durham, North Carolina Area
Industry:
Biotechnology
Qian Zhao Photo 40

System Administrator Iii

Location:
6655 Ridgewood Ave, Cocoa Beach, FL 32931
Industry:
Defense & Space
Work:
Blue Origin
System Administrator Iii Blue Origin
Helpdesk Technician Iii United Launch Alliance (Ula) Sep 2015 - Oct 2017
Communications Engineer University of North Carolina at Chapel Hill Aug 2012 - Aug 2015
Its Control Center Administrator University of North Carolina at Chapel Hill Aug 2011 - Aug 2012
Student Design Assistant University of North Carolina at Chapel Hill Aug 2010 - May 2012
Residential Computing Consultant University of North Carolina at Chapel Hill Aug 2008 - Jan 2011
Student Catalogue Assistant Basf May 2010 - Aug 2010
Summer Intern
Education:
University of North Carolina at Chapel Hill 2008 - 2012
Bachelors, Bachelor of Science, Biochemistry East Chapel Hill High School 2006 - 2008
Naperville North High School 2004 - 2006
Skills:
Data Analysis, Adobe Creative Suite, Microsoft Office, Research, Teaching, Troubleshooting, Graphic Design, Matlab, Microsoft Excel, Microsoft Word, Photoshop, Powerpoint, Javascript, System Monitoring, Information Technology, Ballroom Dance, Computer Science, Chinese, Python, Mathematical Analysis, Traditional Art Skills, Conceptual Art, Paper Carving, Branding and Identity, Laboratory Automation, Chemical Synthesis, Analytical Chemistry, Protein Purification, Microsoft Sql Server, Sharepoint Administration, Visual Basic, Systems Engineering, Microsoft Access, Solarwinds, Telnet, Shell Scripting
Interests:
Artificial Intelligence
Emerging Gadgets
Scientific News
Rts
Education
Environment
Science and Technology
Architecture
Running
Piano
Science Fiction
Space
Animal Welfare
Arts and Culture
Fine Arts (Digital and Pencil)
Languages:
English
Mandarin
Japanese
Qian Zhao Photo 41

Sas Programmer

Location:
Raleigh, NC
Industry:
Computer Software
Work:
ASG
SAS programmer
Education:
Utah State University 1998 - 2007
Qian Zhao Photo 42

Principal Sas Programmer

Location:
976 north 300 east, Logan, UT 84321
Industry:
Pharmaceuticals
Work:
Alkermes
Principal Sas Programmer Ucb Apr 2010 - Jun 2015
Principal Statistical Programmer Iqvia Jan 2007 - Apr 2010
Statistical Programmer
Education:
Utah State University
Skills:
Cdisc, Gcp, Clinical Data Management, Edc, Cro, Clinical Development, Clinical Trials
Interests:
Health
Qian Zhao Photo 43

Field Engineer  - Lwd, Drilling Service

Work:

Field Engineer  - Lwd, Drilling Service
Qian Zhao Photo 44

Qian Zhao

Qian Zhao Photo 45

Qian Zhao

Qian Zhao Photo 46

Qian Zhao

Publications & IP owners

Us Patents

3-Pyrimidin-4-Yl-Oxazolidin-2-Ones As Inhibitors Of Mutant Idh

US Patent:
2018005, Feb 22, 2018
Filed:
Apr 27, 2017
Appl. No.:
15/499824
Inventors:
- Basel, CH
Zhuoliang CHEN - Belmont MA, US
Young Shin CHO - Cambridge MA, US
Abran Q. COSTALES - El Cerrito CA, US
Julian Roy LEVELL - Arlington MA, US
Gang LIU - Waltham MA, US
James R. MANNING - Pleasant Hill CA, US
Martin SENDZIK - Belmont MA, US
Cynthia SHAFER - El Sobrante CA, US
Michael David SHULTZ - Lexington MA, US
James Clifford SUTTON - Pleasanton CA, US
Yaping WANG - Boxborough MA, US
Qian ZHAO - El Cerrito CA, US
International Classification:
C07D 413/14
C07D 417/14
C07D 413/04
A61K 31/506
A61K 31/5377
Abstract:
The invention is directed to a formula (I):or a pharmaceutically acceptable salt thereof, wherein R, R, Rand R-Rare herein. The invention is also directed to compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. The invention is further directed to the use of a compound of formula (I) in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer.

3-Pyrimidin-4-Yl-Oxazolidin-2-Ones As Inhibitors Of Mutant Idh

US Patent:
2016031, Nov 3, 2016
Filed:
Jul 13, 2016
Appl. No.:
15/209731
Inventors:
Thomas Raymond CAFERRO - Abington MA, US
Zhuoliang CHEN - Belmont MA, US
Young Shin CHO - Cambridge MA, US
Abran Q. COSTALES - El Cerrito CA, US
Julian Roy LEVELL - Arlington MA, US
Gang LIU - Waltham MA, US
James R. MANNING - Pleasant Hill CA, US
Martin SENDZIK - Belmont MA, US
Cynthia SHAFER - El Sobrante CA, US
Michael David SHULTZ - Lexington MA, US
James Clifford SUTTON - Pleasanton CA, US
Yaping WANG - Boxborough MA, US
Qian ZHAO - El Cerrito CA, US
Assignee:
NOVARTIS AG - Basel
International Classification:
C07D 413/14
C07D 413/04
C07D 417/14
Abstract:
The invention is directed to a formula (I):or a pharmaceutically acceptable salt thereof, wherein R, R, Rand R-Rare herein. The invention is also directed to compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. The invention is further directed to the use of a compound of formula (I) in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer.

3-Pyrimidin-4-Yl-Oxazolidin-2-Ones As Inhibitors Of Mutant Idh

US Patent:
2015015, Jun 4, 2015
Filed:
Mar 12, 2014
Appl. No.:
14/408418
Inventors:
- Basel, CH
Zhuoliang Chen - Belmont MA, US
Young Shin Cho - Cambridge MA, US
Abran Q. Costales - El Cerrito CA, US
Julian Roy Levell - Arlington MA, US
Gang Liu - Waltham MA, US
James R. Manning - Pleasant Hill CA, US
Martin Sendzik - San Mateo CA, US
Cynthia Shafer - El Sobrante CA, US
Michael David Shultz - Lexington MA, US
James Sutton - Pleasanton CA, US
Yaping Wang - Boxborough MA, US
Qian Zhao - El Cerrito CA, US
Assignee:
NOVARTIS AG - Basel
International Classification:
C07D 413/14
C07D 413/04
A61K 31/5377
A61K 31/506
C07D 417/14
Abstract:
The invention is directed to a formula (I):or a pharmaceutically acceptable salt thereof, wherein R, R, Rand R-Rare herein. The invention is also directed to compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. The invention is further directed to the use of a compound of formula (I) in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer.

3-Pyrimidin-4-Yl-Oxazolidin-2-Ones As Inhibitors Of Mutant Idh

US Patent:
2014027, Sep 18, 2014
Filed:
Mar 13, 2014
Appl. No.:
14/208015
Inventors:
Thomas Raymond CAFERRO - Abington MA, US
Zhuoliang CHEN - Belmont MA, US
Young Shin CHO - Cambridge MA, US
Abran Q. COSTALES - El Cerrito CA, US
Julian Roy LEVELL - Arlington MA, US
Gang LIU - Waltham MA, US
James R. MANNING - Pleasant Hill CA, US
Martin SENDZIK - San Mateo CA, US
Cynthia SHAFER - El Sobrante CA, US
Michael David SHULTZ - Lexington MA, US
James SUTTON - Pleasanton CA, US
Yaping WANG - Boxborough MA, US
Qian ZHAO - El Cerrito CA, US
Assignee:
NOVARTIS AG - Basel
International Classification:
C07D 413/04
A61K 31/5377
C07D 417/14
C07D 413/14
A61K 31/506
US Classification:
5142358, 544324, 514275, 544296, 544295, 51425505, 51425219, 544122
Abstract:
The invention is directed to a formula (I):or a pharmaceutically acceptable salt thereof, wherein R, R, Rand R-Rare herein. The invention is also directed to compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. The invention is further directed to the use of a compound of formula (I) in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer.

3-Pyrimidin-4-Yl-Oxazolidin-2-Ones As Inhibitors Of Mutant Idh

US Patent:
2014023, Aug 21, 2014
Filed:
Sep 26, 2012
Appl. No.:
14/347481
Inventors:
- Aarhus N, DK
Young Shin Cho - Cambridge MA, US
Abran Q. Costales - El Cerrito CA, US
Huangshu Lei - Chongqing, CN
Francois Lenoir - Waltham MA, US
Julian Roy Levell - Arlington MA, US
Gang Liu - Waltham MA, US
Mark G. Palermo - Rindge NH, US
Keith Bruce Pfister - San Ramon CA, US
Martin Sendzik - San Mateo CA, US
Cynthia Shafer - El Sobrante CA, US
Michael David Shultz - Lexington MA, US
Troy Smith - Nashua NH, US
James Clifford Sutton - Pleasanton CA, US
Bakary-Barry Toure - Weston MA, US
Fan Yang - West Roxbury MA, US
Qian Zhao - El Cerrito CA, US
Assignee:
NOVARTIS AG - Basel
International Classification:
C07D 413/14
A61K 31/506
A61K 31/5377
C07D 498/10
A61K 31/551
C07D 471/04
C07D 487/08
C07D 417/14
C07D 413/04
C07D 487/04
US Classification:
514218, 544324, 514275, 544295, 51425219, 544122, 5142358, 514249, 540575, 544296, 514269
Abstract:
The invention is directed to a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R-Rare defined herein. The invention is also directed to compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. The invention is further directed to the use of a compound of formula (I) in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer.

Possible Relatives

Dayu C Zhao  Daisy Zhao  Danan Q Zhao  Ding J Zhao  Dong Zhao  Dongsheng Zhao  Elaine Zhao  Qian Lin  Qian Liu  Qian C Chen 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.